direct access: sarepta, eteplirsen with chris garabedian (oct 2012)
Published 12 years ago • 2.6K plays • Length 1:20:12Download video MP4
Download video MP3
Similar videos
-
58:43
avi clinical trial update (3/2012)
-
26:23
how you can participate in the sarepta ad comm
-
1:07
sarepta's rolling nda submission - a conversation with chris garabedian
-
3:10
chris garabedian, ceo, sarepta therapeutics
-
5:17
chris garabedian discusses his time at sarepta
-
18:37
in the pipeline: restoring dystrophin - sarepta therapeutics (rna targeted therapies)
-
1:18
former ceo of sarepta discusses the current duchenne drug landscape
-
28:49
dvm karin leibbrandt - replay international meeting stop hyperflexion collectif pour les chevaux.
-
3:31
duchenne muscular dystrophy (dmd) mechanism of disease
-
1:28
prosensa's video animation on exon skipping
-
3:45
patient testimonial | ms. pratistha - cauda equina syndrome
-
14:42
sarepta therapeutics (eteplirsen) [ppmd's 2015 connect conference]
-
0:59
sareptassist - supporting duchenne families
-
4:00
chris garabedian discusses his time at sarepta
-
5:05
chris garabedian discusses interacting with duchenne patients and advocates
-
25:43
chris garabedian of sarepta on personalized medicine at world orphan drug congress usa 13
-
0:47
sareptassist - dedicated to supporting duchenne families
-
0:52
sareptassist - duchenne support & resources
-
1:01:36
[webinar] introducing ppmo – sarepta therapeutics – may 2018
-
1:10
sareptassist - duchenne family story
-
47:34
[webinar] sareptassist patient services overview - september 2016